Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Fish and Richardson
Express Scripts
Cipla
Cerilliant
Merck
Moodys
US Department of Justice

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062170

« Back to Dashboard

NDA 062170 describes KLEBCIL, which is a drug marketed by King Pharms and is included in one NDA. Additional details are available on the KLEBCIL profile page.

The generic ingredient in KLEBCIL is kanamycin sulfate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the kanamycin sulfate profile page.
Summary for 062170
Tradename:KLEBCIL
Applicant:King Pharms
Ingredient:kanamycin sulfate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 062170

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 75MG BASE/2ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/2ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/3ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Daiichi Sankyo
Colorcon
McKesson
Boehringer Ingelheim
Chubb
Moodys
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.